Barrett, Hilary E.
Meester, Eric J.
van Gaalen, Kim
van der Heiden, Kim
Krenning, Boudewijn J.
Beekman, Freek J.
de Blois, Erik
de Swart, Jan
Verhagen, H J
Maina, Theodosia
Nock, Berthold A.
Norenberg, Jeffrey P.
de Jong, Marion
Gijsen, Frank J. H.
Bernsen, Monique R.
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (707404)
Erasmus Medisch Centrum
Netherlands Heart Foundation (NHS2014T096)
Article History
Received: 25 September 2019
Accepted: 18 March 2020
First Online: 15 April 2020
Compliance with ethical standards
:
: F.J. Beekman is founder, CEO and shareholder of MILabs. B.V., the vendor of the VECTor5/CT system, and J. Norenberg holds the patent on [<sup>111</sup>In]In-Danbirt.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Erasmus Medical Centre’s research committee (MEC 2008-147) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.